On air · 2 of 3 networks
Cusabio Technology LLC
- cusabio.com
- Healthcare & Life Sciences
- US
- 36 employees
Cusabio Technology LLC’s ads on LinkedIn, Meta and Google, recorded by adsrunning. Browse the latest here for free. Sign up free to see all 56. Watch Cusabio Technology LLC with Starter to get each new one in your feed.
Watchlist with Starter · $49/mo
| Network | Status | Live ads | Nov 2025LinkedIn activity · 52 weeksOct 2026 | Checked | Next step |
|---|---|---|---|---|---|
| Running | 52 | Checked 30 Oct 2026 | See all 56 ads → | ||
| Meta | None recorded | 0 | No active ads recorded on the Meta Ad Library | Checked 19 Oct 2026 | Collect them with the API → |
| Running | 100+ | Ads on the Google Ads Transparency Center | Checked 26 Oct 2026 | Collect them with the API → |
Cusabio Technology LLC has 52 live LinkedIn ads. Its Facebook page had no active ads on 19 Oct 2026, and we recorded 100+ Google ads on 26 Oct 2026.
Latest ads
- LINKEDIN · IMAGESince 12 Aug 2026
🔬 CUSABIO is thrilled to announce a limited-time offer on our high-quality antibodies! Get premium in-stock antibodies for just $49.90 / 100µg (or 100µL), valid through Oct 20. With 3,000+ In-Stock Targets and rigorous QC validation (WB, IHC, ELISA), CUSABIO provides fast-delivery solutions to power your research in oncology, immunology, and beyond. 👇 Click below to browse the catalog and buy now! #CUSABIO #Antibodies #RecombinantAntibodies #MonoclonalAntibodies #LifeScienceResearch #BiomedicalResearch
- LINKEDIN · IMAGESince 12 Aug 2026
🔬 CUSABIO is thrilled to announce a limited-time offer on our high-quality antibodies! Get premium in-stock antibodies for just $49.90 / 100µg (or 100µL), valid through Oct 20. With 3,000+ In-Stock Targets and rigorous QC validation (WB, IHC, ELISA), CUSABIO provides fast-delivery solutions to power your research in oncology, immunology, and beyond. 👇 Click below to browse the catalog and buy now!
- LINKEDIN · EVENTSince 20 Oct 2025
🔬 Join CUSABIO’s Webinar: “Antibody Discovery – Single B Cell Platforms” 🗓️ Date: November 5, 2025 🕒 Time: 【2:00 pm CET】 Explore how Single B Cell Technology accelerates the discovery of high-quality, native-paired antibodies — reducing discovery time from months to weeks. 💡 Key Highlights: • Bypass hybridoma to capture diverse, native antibodies • Rapid murine mAb discovery cases from CUSABIO • Alpaca VHH (Nanobody) development for enhanced stability & tissue penetration Don’t miss this chance to learn how single B cell platforms are reshaping antibody R&D. 👉 Register now! 🔗 https://lnkd.in/ghvduuF9 #CUSABIO #Webinar #AntibodyDiscovery #SingleBCell #Nanobody #Biotech #LifeSciences #ResearchInnovation
- LINKEDIN · ARTICLERecorded 14 Sept 2026
CD47, A New Target for Tumor Immune
- LINKEDIN · ARTICLERecorded 14 Sept 2026
Nicotinic Acetylcholine Receptor α1 Subunit (CHRNA1): Structure, Functional Mechanisms, and Disease-Related Research Progress
- LINKEDIN · EVENTRecorded 14 Sept 2026
🔬 Join CUSABIO’s Webinar: “Antibody Discovery – Single B Cell Platforms” 🗓️ Date: November 5, 2025 🕒 Time: 【3:30 pm JST/KST】 Explore how Single B Cell Technology accelerates the discovery of high-quality, native-paired antibodies — reducing discovery time from months to weeks. 💡 Key Highlights: • Bypass hybridoma to capture diverse, native antibodies • Rapid murine mAb discovery cases from CUSABIO • Alpaca VHH (Nanobody) development for enhanced stability & tissue penetration Don’t miss this chance to learn how single B cell platforms are reshaping antibody R&D. 👉 Register now! 🔗 https://lnkd.in/ghvduuF9 #CUSABIO #Webinar #AntibodyDiscovery #SingleBCell #Nanobody #Biotech #LifeSciences #ResearchInnovation
6 of 56 adsSign up to see every Cusabio Technology LLC ad, filter by format and date, and get alerts on new ones.
See all 56 adsWatch the companies you care about.
Filter every ad by industry, country, format and network, and get alerts when a company you watch starts running new ads.